logo

CRDL

Cardiol Therapeutics·NASDAQ
--
--(--)
--
--(--)

CRDL fundamentals

Cardiol Therapeutics (CRDL) released its earnings on Nov 13, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.0862 (YoY +35.19%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.0862
+35.19%
Report date
Nov 13, 2025
EPS
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Q3,2025
Actual
-0.1292-0.1813-0.087-0.1119-0.0776-0.0939-0.0885-0.0813-0.0905-0.0662-0.0905-0.1033-0.0731-0.133-0.0695-0.0695-0.0735-0.0862
Forecast
-0.1131-0.1103-0.1107-0.1359-0.1009-0.1048-0.059-0.0813-0.0943-0.0883-0.0905-0.0883-0.1033-0.0942-0.0881-0.0799-0.0808-0.0715
Surprise
-14.24%
-64.37%
+21.41%
+17.66%
+23.09%
+10.40%
-50.00%
0.00%
+4.03%
+25.03%
0.00%
-16.99%
+29.24%
-41.19%
+21.11%
+13.02%
+9.03%
-20.56%
Revenue
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Q3,2025
Actual
63.60K00000000000000000
Forecast
000000000000000000
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Earnings Call